Hyperdopaminergic Status in Experimental Huntington Disease

Strategic Insights -

Recent research has shed light on the molecular mechanisms underlying Huntington's disease, a genetic disorder that causes progressive damage to the brain. A study conducted by A. Jahanshahi and colleagues at the University Medical Center in Maastricht, Netherlands, has discovered a significant link between hyperdopaminergic status and the development of chorea, a hallmark symptom of the disease. The researchers found that increased dopamine levels in the striatum, a region of the brain responsible for motor control, come from the substantia nigra pars compacta and ventral tegmental area, two main nuclei that supply dopamine to the striatum.

Key Takeaways:

  • The study found that Huntington's disease is associated with increased dopaminergic neurotransmission in the striatum, which can be treated with dopamine antagonist or dopamine-depleting drugs.
  • The origin of the hyperdopaminergic status in Huntington's disease remains unknown, but the study suggests that changes in the substantia nigra pars compacta and ventral tegmental area may contribute to this condition.
  • The researchers used a transgenic rat model of Huntington's disease, which exhibits progressive striatal neurodegeneration and chorea, to investigate the molecular mechanisms underlying the development of this disease.
  • The study demonstrated increased dopamine levels in the striatum and more dopaminergic cells in the substantia nigra pars compacta and ventral tegmental area in the rat model.
  • The findings of the study implicate increased dopamine input from the substantia nigra pars compacta and ventral tegmental area in the pathogenesis of chorea in Huntington's disease.
  • The study provides evidence that the hyperdopaminergic status in Huntington's disease is not necessarily related to shrinkage of the striatum.

Statistics:

  • 910-7: The page numbers of the journal article in the Journal of Neuropathology and Experimental Neurology.
  • 2010: The year of publication of the study.
  • 69(9): The volume and issue number of the journal where the study was published.
  • 1-7: The page numbers where the study was published.

Sources:

  • Jahanshahi A, et al. (2010) Hyperdopaminergic status in experimental Huntington disease. Journal of Neuropathology and Experimental Neurology, 69(9), 910-917.
  • American Assn Neuropathologists Inc. (Publisher contact information) Address: 1041 New Hampshire St., Lawrence, KS 66044, USA.